🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Daratumumab Vennetoclax Dexamethasone is the answer for t(11;14) myeloma. youtu.be/dG71msMazUA

apple.news/AlloXdtzKSIaBe…

apple.news/AqFcUujQBQXWfG…

y RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease dx.doi.org/10.1158/2159-8… L

This explains the neutropenia seen in myeloma patients treated with therapies targeting normal plasma cells. doi.org/10.1016/j.immu… Plasma Cells Are Obligate Effectors of Enhanced Myelopoiesis in Aging Bone Marrow. Immunity 2019

CellCentric receives FDA Fast Track designation for relapsed refractory multiple myeloma drug on Labiotech.eu labiotech.eu/trends-news/ce…

firstwordpharma.com/story/5759799 CellCentric announces $25m strategic investment from Pfizer

Jonathan Keats you'll thank me one day...

The fascinating story of Thalidomide: how this most notorious drug on the planet, banned in the 1960s, made an incredible comeback and revolutionized the treatment of myeloma. I will also highlight one person whose role is not recognized: Without Dr. Leif Bergsagel there will

Check out the following survey on Revlimid maintenance: surveymonkey.com/s/ZGNYBTN

National Cancer Institute Awards SPORE grant to multiple myeloma research team from Mayo Clinic Cancer Center newsnetwork.mayoclinic.org/discussion/nat…

How does Revlimid work in #myeloma? This article in Nature Medicine shows it blocks the lactate exporter. dx.doi.org/10.1038/nm.4128

Off label use of Thalidomide and Lenalidomide has helped thousands of myeloma patients despite whistleblower claims tinyurl.com/hqullh7

Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. nature.com/doifinder/10.1…